Midway Hudson - Ashley in Ashley, IN - Clinic/Center

Midway Hudson - Ashley is a primary clinic (Clinic/center - Multi-specialty) in Ashley, Indiana. The current practice location for Midway Hudson - Ashley is 105 In-4, Ashley, Indiana. For appointments, you can reach them via phone at (260) 589-3288. The mailing address for Midway Hudson - Ashley is 5500 Maryland Way, Brentwood, Tennessee and phone number is () -.

Midway Hudson - Ashley is licensed to practice in * (Not Available) (license number ) and its NPI number is 1821764226. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (260) 589-3288.

Contact Information

	Midway Hudson - Ashley
	105 In-4 Ashley IN 46705
	(260) 589-3288
	Not Available

Primary Care Clinic Profile

Full Name	Midway Hudson - Ashley
Speciality	Clinic/center - Multi-specialty
Location	105 In-4, Ashley, Indiana
Authorized Official Name and Position	Jonathan Leizman (PRESIDENT)
Authorized Official Contact	2164799063
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Midway Hudson - Ashley 5500 Maryland Way Brentwood TN 37027-7048 Ph: () -	Midway Hudson - Ashley 105 In-4 Ashley IN 46705 Ph: (260) 589-3288

NPI Details:

NPI Number	1821764226
Provider Enumeration Date	08/17/2021
Last Update Date	08/15/2022

Medical Identifiers

Medical identifiers for Midway Hudson - Ashley such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1821764226	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261QM1300X	Clinic/center - Multi-specialty	(* (Not Available))	Primary

News Archive

RaySearch Laboratories restructures license agreement with Varian Medical Systems

RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.

Cempra to present solithromycin Phase 1 study data at ECCMID/ICC meeting

Cempra Pharmaceuticals, a developer of differentiated antibiotics, today announced an oral presentation showing that intravenous (IV) solithromycin demonstrates excellent tolerability and a favorable pharmacokinetic profile at IV doses up to 800 mg.

Obama promotes health bill, asks people to give it time to work

Los Angeles Times: Ihe president said "it would take four years for the overhaul to be fully implemented but that some provisions would kick in quickly. Those include ending insurance company practices of using preexisting conditions as an excuse to curb benefits and lifting annual caps on payments. ... The president also stressed the advantages for small-business owners.

Scientists identify unique function of Twist1 in tumor metastasis

In the early stages of human embryogenesis, a transcription factor called Twist1 plays a key regulatory role in how the embryo assumes form and function. Much later in life, however, researchers at the University of California, San Diego School of Medicine, say Twist1 can re-emerge, taking a darker and more deadly turn.

Midway Hudson - Ashley - Primary Care in Ashley, IN